+ 33 1 46 99 68 20

 

A portfolio of essential medicines

DELBERT Pharma offers several specialties in three main therapeutic areas:

5

Infectiology & Pneumology

5

Neurology

5

Onco-hematology

These medicines are developed and manufactured to the highest standards.
Our selection of partners is mainly based on European production sites whose quality of work is based on GMP (Good Manufacturing Practice), the European Pharmacopoeia and compliance with European environmental requirements.

> 60 %

of our products are MITMs (drugs of major therapeutic interest)

> 60 %

of our products are made in France

> 90 %

API are from European companies

> 90 %

of our suppliers are European

Our therapeutic areas

and our main products

Infectiology & Pneumology

Amikacin

Amukin®

France

Amoxicillin

Xyllomac®

(France)

Delamoxyle®

(Belgium – Luxembourg)

Delamoxyl®

(Switzerland)

Amoxicillin and clavulanic acid

Benzathine benzylpenicillin

Extencilline®

(France)

Extencin®

(Netherlands)

Benzylpenicillin benzathine

(United Kingdom)

N-acetylcysteine

Oxacillin

Istopen®

(France)

Penstapho®

(Italy)

Prostaphlin®

(Czech Republic)

Oncology & Hematology

Histamine dihydrochloride

Pipobroman

Neurology

Lithium carbonate

Tropatépine hydrochloride

Pipotiazine palmitic ester

Lorazepam

Some of our products may be available internationally through our distributors, under different trade names. Please contact us to find out more.

REQUEST MEDICAL INFORMATION - REPORT AN ADVERSE EVENT

To request medical information on DELBERT Pharma products or report an adverse event,

please write to pharmacovigilance@delbert.fr or contact us on + 33 1 46 99 68 20